Clinical outcomes of sacroplasty for metastatic sacral tumours: a systematic review and meta-analysis

Study design A systematic review and meta-analysis. Objective The purpose of this study was to evaluate the clinical outcome and safety of sacroplasty for patients with secondary metastatic lesions to the sacrum. Methods Several databases, including the Cochrane library, PubMed and EMBASE, were syst...

Full description

Saved in:
Bibliographic Details
Published in:European spine journal 2020-12, Vol.29 (12), p.3116-3122
Main Authors: Tarawneh, Ahmad M., Sabou, Silviu, AlKalbani, Sultan, Pasku, Dritan, Quraishi, Nasir A.
Format: Article
Language:English
Subjects:
Clinical outcomes
Complications
Medicine
Medicine & Public Health
Meta-analysis
Metastases
Metastasis
Neurosurgery
Review Article
Sacrum
Surgical Orthopedics
Systematic review
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Study design A systematic review and meta-analysis. Objective The purpose of this study was to evaluate the clinical outcome and safety of sacroplasty for patients with secondary metastatic lesions to the sacrum. Methods Several databases, including the Cochrane library, PubMed and EMBASE, were systematically searched to identify potentially eligible articles in English language. All the above databases were searched until December 2019. The search strategy was based on the combination of the following keywords: sacroplasty AND secondary tumours OR metastasis OR metastases. The reference list of the selected literature was also reviewed and a standard PRISMA template utilised. Results From a total of 102 articles initially identified, a final seven studies were identified as meeting the inclusion criteria. A total of 107 patients from these studies were included. The follow-up ranged from immediate post-operatively to 30.5 months. The mean preoperative VAS was 8.38 (range 6.9–9.3), which improved significantly to 3.01 (range 1.12–4.7) post-operatively ( p  
ISSN:0940-6719
1432-0932
DOI:10.1007/s00586-020-06562-w